特应性皮炎诊疗指南（专科医生版本、全科医生版本和患者版本）计划书

doi:10.35541/cjd.20230248

Abstract

Abstract: 【Abstract】 In order to further standardize the diagnosis and treatment of atopic dermatitis by health-care professionals, as well as to enhance the awareness of atopic dermatitis among patients and promote doctor-patient communication, Chinese Society of Dermatology and China Dermatologist Association jointly initiated the development of guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）. The development working group had planned the development process of the 3 versions of guidelines with reference to relevant development manuals and methodological articles. It is also intended to expound the details of registration, working group establishment, clinical question collection, evidence search and grading, recommendation formation and consensus through this protocol, aiming to enhance the transparency of guideline development.

Key words: Dermatitis, atopic, Physicians, Patients, Guideline, Protocol

Guo Hao, Liu Hui, Zhang Li, Zhu Guannan, Wang Ping, Yao Zhirong, Gao Xinghua, Chen Yaolong, . Protocols for guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）[J]. Chinese Journal of Dermatology, 2023, 56(9): 809-814.doi:10.35541/cjd.20230248

References ［26］

［1］	Ständer S. Atopic dermatitis［J］. N Engl J Med, 2021,384（12）:1136⁃1143. doi: 10.1056/NEJMra2023911.
［2］	Dong WL, An J, Yu M, et al. The prevalence and year lived with disability of atopic dermatitis in China: findings from the global burden of disease study 2019［J］. World Allergy Organ J, 2021,14（11）:100604. doi: 10.1016/j.waojou.2021.100604.
［3］	Cheng J, Wu JJ, Han G. Epidemiology and characterization of atopic dermatitis in East Asian populations: a systematic review［J］. Dermatol Ther （Heidelb）, 2021,11（3）:707⁃717. doi: 10. 1007/s13555⁃021⁃00516⁃w.
［4］	Laughter MR, Maymone M, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990⁃2017［J］. Br J Dermatol, 2021,184（2）:304⁃309. doi: 10.1111/bjd.19580.
［5］	Wang X, Li LF, Zhao DY, et al. Prevalence and clinical features of atopic dermatitis in China［J］. Biomed Res Int, 2016,2016:2568301. doi: 10.1155/2016/2568301.
［6］	Guo Y, Li P, Tang J, et al. Prevalence of atopic dermatitis in Chinese children aged 1 - 7 ys［J］. Sci Rep, 2016,6:29751. doi: 10.1038/srep29751.
［7］	UpToDate. Atopic dermatitis （eczema）: pathogenesis, clinical manifestations, and diagnosis［EB/OL］.（2022⁃9⁃28）［2023⁃7⁃18］. https://www.uptodate.com/contents/atopic⁃dermatitis⁃eczema⁃ pathogenesis⁃clinical⁃manifestations⁃and⁃diagnosis.
［8］	Langan SM, Irvine AD, Weidinger S. Atopic dermatitis［J］. Lancet, 2020,396（10247）:345⁃360. doi: 10.1016/S0140⁃6736（20）31286⁃1.
［9］	World Health Organization. WHO handbook for guideline development. 2nd Ed ［M/OL］. （2014⁃12⁃18）［2023⁃07⁃18］. https://www.who.int/publications/i/item/9789241548960.
［10］	陈耀龙, 杨克虎, 王小钦, 等. 中国制订/修订临床诊疗指南的指导原则（2022版）［J］. 中华医学杂志, 2022,102（10）:697⁃703. doi: 10.3760/cma.j.cn112137⁃20211228⁃02911.
［11］	Brouwers MC, Kho ME, Browman GP, et al. AGREEⅡ: advancing guideline development, reporting and evaluation in health care［J］. CMAJ, 2010,182（18）:E839⁃842. doi: 10.1503/cmaj.090449.
［12］	杨楠, 赵巍, 潘旸, 等. 针对临床实践指南科学性、透明性和适用性的评级工具研发［J］. 中华医学杂志, 2022,102（30）:2329⁃2337. doi: 10.3760/cma.j.cn112137⁃20220219⁃00340.
［13］	Guidelines International Network （GIN）. GIN PUBLIC Toolkit: patient and public involvement in guidelines［M/OL］. ［2022⁃11⁃3］. https://g⁃i⁃n.net/wp⁃content/uploads/2021/04/GIN⁃TOOLKIT⁃COMBINED⁃FINAL⁃2015.pdf
［14］	陈耀龙, 荀杨芹, 李博, 等. 如何制订患者指南［J］. 协和医学杂志, 2020,11（4）:453⁃458. doi: 10.3969/j.issn.1674⁃9081.2020. 04.017.
［15］	陈耀龙, 马艳芳, 周奇, 等.谁应该参与临床实践指南的制订?［J］. 协和医学杂志, 2019,10（5）:524⁃530. doi: 10.3969/j.issn.1674⁃9081.2019.05.017.
［16］	Ma LL, Wang YY, Yang ZH, et al. Methodological quality （risk of bias） assessment tools for primary and secondary medical studies: what are they and which is better?［J］. Mil Med Res, 2020,7（1）:7. doi: 10.1186/s40779⁃020⁃00238⁃8.
［17］	Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations［J］. BMJ, 2008,336（7650）:924⁃926. doi: 10. 1136/bmj.39489.470347.AD.
［18］	中华医学会儿科学分会临床药理学组, 中华医学会儿科学分会呼吸学组, 刘恩梅, 等.中国儿童咳嗽指南（2021患者版）［J］.儿科药学杂志, 2021,27（S1）:17⁃22. doi: 10.13407/j.cnki.jpp.1672⁃108X.2021.S1.009.
［19］	Zhang Y, Coello PA, Brożek J, et al. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach［J］. Health Qual Life Outcomes, 2017,15（1）:52. doi: 10.1186/s12955⁃017⁃0621⁃0.
［20］	刘辉, 王华, 刘云兰, 等. 中国儿童消化道异物管理指南（患者与公众版，2022）计划书［J］. 中国实用儿科杂志, 2022,37（2）:81⁃87.
［21］	Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement［J］. Ann Intern Med, 2017,166（2）:128⁃132. doi: 10.7326/M16⁃1565.
［22］	王平, 周奇, 赵俊贤, 等. 临床实践指南基层版报告规范的研发［J］.中国全科医学, 2023,26（13）:1543⁃1550. doi: 10.12114/j.issn.1007⁃9572.2023.0043.
［23］	Wang X, Chen Y, Akl EA, et al. The reporting checklist for public versions of guidelines: RIGHT⁃PVG［J］. Implement Sci, 2021,16（1）:10. doi: 10.1186/s13012⁃020⁃01066⁃z.
［24］	周奇, 王小琴, 姚亮, 等. 临床实践指南更新的若干关键问题［J］. 中国循证儿科杂志, 2016,11（5）:392⁃397. doi: 10.3969/j.issn.1673⁃5501.2016.05.016.
［25］	Ghazal S, Ridha Z, D′Aguanno K, et al. Treatment guidelines for atopic dermatitis since the approval of dupilumab: a systematic review and quality appraisal using AGREE⁃Ⅱ［J］. Front Med （Lausanne）, 2022,9:821871. doi: 10.3389/fmed.2022.821871.
［26］	叶城斌, 邹颖. 不同国家及地区特应性皮炎治疗指南的比较［J］. 中国皮肤性病学杂志, 2020,34（11）:1331⁃1336,1340. doi: 10.13735/j.cjdv.1001⁃7089.202003205.

[1]	Wang Yuqian, Qiao Jianjun, Fang Hong. Comparison of the latest Chinese and international guidelines/consensus on diagnosis and treatment of alopecia areata [J]. Chinese Journal of Dermatology, 2023, 56(9): 885-888.
[2]	Chen Yaolong, Liu Hui, Yao Zhirong, Gao Xinghua. Strategies and suggestions for improving the quality of guidelines and consensus in the field of dermatology [J]. Chinese Journal of Dermatology, 2023, 56(9): 805-808.
[3]	Committee on Psoriasis, Chinese Society of Dermatology. Guideline for the diagnosis and treatment of psoriasis in China （2023 edition） [J]. Chinese Journal of Dermatology, 2023, 56(7): 573-625.
[4]	China Dermatologist Association, Chinese Society of Dermatology, Xijing Hospital, Air Force Medical University, Chinese Dietary Guideline for Psoriasis Patients Task Force. Dietary guideline for patients with psoriasis in China （2023） [J]. Chinese Journal of Dermatology, 2023, 56(5): 389-401.
[5]	Jia Weixue, Li Chengrang. Comparison of Chinese and international guidelines and consensus for the diagnosis and treatment of vitiligo [J]. Chinese Journal of Dermatology, 2023, 56(5): 471-475.
[6]	Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin. Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303.
[7]	Environmental and Occupational Skin Disease Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Group on Children, Chinese Society of Dermatology. Expert consensus on clinical application of wet-wrap therapy for atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 289-294.
[8]	Centre for Urticaria Research, Chinese Society of Dermatology. Guidelines for education of patients with chronic urticaria (2022) [J]. Chinese Journal of Dermatology, 2022, 0(4): 20220305-e20220305.
[9]	Wang Zhaoyang, Chen Anwei, Xiang Xin, Luo Xiaoyan, Xu Zigang, Wang Hua, Ma Lin. An investigation into the current situation of pediatric psoriasis based on the information systems from two children′s hospitals [J]. Chinese Journal of Dermatology, 2022, 55(3): 246-250.
[10]	Zhang Guoyi, Gong Xiangdong, Zhu Bokun, Liu Chuanxia, Jing Linghua, Xu Jinyu. Patterns of skin diseases among outpatients attending Hospital of Dermatology of Chinese Academy of Medical Sciences in 2019 [J]. Chinese Journal of Dermatology, 2022, 55(2): 150-152.
[11]	Centre for Urticaria Research, Chinese Society of Dermatology. Guideline for diagnosis and treatment of urticaria in China （2022） [J]. Chinese Journal of Dermatology, 2022, 55(12): 1041-1049.
[12]	Chinese Dermatologist Association. Expert consensus on clinical application of aminolevulinic acid-based photodynamic therapy in the treatment of acne vulgaris （2022） [J]. Chinese Journal of Dermatology, 2022, 55(12): 1050-1057.
[13]	Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases. Chinese Expert consensus on the diagnosis and treatment of adult dermatomyositis （2022） [J]. Chinese Journal of Dermatology, 2022, 55(11): 939-949.
[14]	Laser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association, Cosmetic Laser Group, Chinese Society of Dermatology, Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association. Consensus on treatment of acne scars in China （2021） [J]. Chinese Journal of Dermatology, 2021, 54(9): 747-756.
[15]	Skin Tumor Research Center, Chinese Society of Dermatology, Subcommittee on Skin Tumor, China Dermatologist Association. Consensus on diagnosis and treatment of cutaneous squamous cell carcinoma （2021） [J]. Chinese Journal of Dermatology, 2021, 54(8): 653-664.

Protocols for guidelines on the diagnosis and treatment of atopic dermatitis （specialist version, general practitioner version and patient version）

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［26］

Related Articles 15

Metrics

Comments

Recommended 10